B2Pharm unveils green list alert service

Published: 2013-08-29 07:00:00

Updated: 2013-08-29 07:00:00

B2Pharm, the local information provider for pharmaceutical business, said Tuesday it has It “green list alert service” (GLAS) for Korean drug makers.

The GLAS is designed to provide customers with updated patent information of medicinal products listed in the green list, including patent litig...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK